I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
The CADTH pCODR Expert Review Committee Process Explained. ..:
Trudeau, Maureen
;
Fraser, Brent
Current Oncology. 30 (2023) 5 - p. 5047-5049 , 2023
Link:
https://doi.org/10.3390/curroncol30050380
RT Journal T1
The CADTH pCODR Expert Review Committee Process Explained. Comment on Rayson et al. Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain. Curr. Oncol. 2022, 29, 9891–9895
UL https://suche.suub.uni-bremen.de/peid=cr-10.3390_curroncol30050380&Exemplar=1&LAN=DE A1 Trudeau, Maureen A1 Fraser, Brent PB MDPI AG YR 2023 SN 1718-7729 JF Current Oncology VO 30 IS 5 SP 5047 OP 5049 LK http://dx.doi.org/https://doi.org/10.3390/curroncol30050380 DO https://doi.org/10.3390/curroncol30050380 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)